Ligand Pharmaceuticals Inc (LGND)
R&D to Revenue
23.03%
Quarterly · Period ending:
LGND R&D to Revenue
Latest reported23.03%period ending
Latest reported23.03%period ending
LGND Quarterly R&D/Revenue (0.00% → 23.03%)
Latest values, visible window
High-resolution chart · PNG
LGND r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 75.4246% | |
| 72.8207% | |
| 94.176% | |
| 109.6023% | |
| 118.522% | |
| 107.1043% | |
| 117.7419% | |
| 160.2041% | |
| 173.8095% | |
| 140.7767% | |
| 500% | |
| 435.8974% | |
| 393.1818% | |
| 292.1569% | |
| 96.3303% | |
| 176.4706% | |
| 168.6869% | |
| 169.3878% | |
| 180.2083% | |
| 148.5149% | |
| 174.1176% | |
| 139.7727% | |
| 168.3544% | |
| 183.3333% | |
| 0% | |
| 152.1739% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |